Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 40Colorectal Neoplasms 25Colonic Neoplasms 10Brain Neoplasms 8Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Neoplasm Metastasis 6Rectal Neoplasms 5Skin Neoplasms 4Lung Neoplasms 3Gastrointestinal Neoplasms 3Pancreatic Neoplasms 2Digestive System Neoplasms 2Thyroid Neoplasms 1Solid Tumors Harboring a BRAF V600 Mutation 1Solid Tumors 1Solid Tumor 1Skin Diseases 1Recurrence 1Rectal Diseases 1Neurofibromatosis 1 1Multiple Myeloma 1Lymphatic Metastasis 1Leukemia, Hairy Cell 1Intestinal Neoplasms 1Intestinal Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Gliosarcoma 1Glioma 1

Interventions

alvimopan 5Irinotecan 4Oxaliplatin 3Capecitabine 3Bevacizumab 3Surveys and Questionnaires 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Colonoscopy 2Cetuximab 2Aspirin 2repotrectinib 1pralsetinib 1pembrolizumab 1napabucasin 1lutetium Lu 177 dotatate 1guadecitabine 1encorafenib 1copper dotatate CU-64 1alectinib 1Ursodeoxycholic Acid 1Surgical Procedures, Operative 1Pemetrexed 1Oviposition 1Ocoxin 1Lutetium-177 1Lutetium 1Low Density Lipoprotein Receptor-Related Protein-1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Diseases × encorafenib × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡